Previous 10 | Next 10 |
Sesen Bio Inc. (NASDAQ:SESN) traded today at a new 52-week high of $4.36. This new high was reached on below average trading volume as 1.2 million shares traded hands, while the average 30-day volume is approximately 5.9 million shares. Sesen Bio Inc. (NASDAQ:SESN) defies analysts with a...
After years of brewing its medicine, Sesen is poised to gain FDA approval for Vicineum as a treatment for non-muscle-invasive bladder cancer. In the VISTA trial, Vicineum demonstrated robust efficacy which trumped all competing molecules. Epitomized as a run-up phenomenon, Sesen s...
Shares of Sesen Bio Inc. (NASDAQ:SESN) traded today at $4.17, eclipsing its 52-week high. This new high was reached on below average trading volume as 1.2 million shares traded hands, while the average 30-day volume is approximately 5.4 million shares. Sesen Bio Inc is a late-stage clini...
3 Biotech Penny Stocks for Your June Watchlist Biotech penny stocks have without a doubt been some of the hottest small-caps of the year. When the pandemic first hit at the beginning of 2020, most biotech companies saw their shares shoot down dramatically alongside the entire market. Ho...
Sesen Bio Inc. (NASDAQ:SESN) traded today at a new 52-week high of $3.87. Approximately 1.2 million shares have changed hands today, as compared to an average 30-day volume of 5.4 million shares. Sesen Bio Inc. share prices have moved between a 52-week high of $3.87 and a 52-week low of ...
Shares of Sesen Bio Inc. (NASDAQ:SESN) traded at a new 52-week high today of $3.77. Approximately 1.2 million shares have changed hands today, as compared to an average 30-day volume of 5.4 million shares. Sesen Bio Inc. share prices have moved between a 52-week high of $3.77 and a 52-we...
Shares of Sesen Bio Inc. (NASDAQ:SESN) traded at a new 52-week high today of $3.82. This new high was reached on below average trading volume as 1.2 million shares traded hands, while the average 30-day volume is approximately 5.4 million shares. Based on a current price of $3.79, Sesen ...
Shares of Sesen Bio Inc. (NASDAQ:SESN) traded at a new 52-week high today of $3.92. This new high was reached on below average trading volume as 1.2 million shares traded hands, while the average 30-day volume is approximately 5.4 million shares. Sesen Bio Inc is a late-stage clinical co...
Sesen Bio ([[SESN]] -5.6%) has entered into a global supply agreement for Vicineum with the company's partner in China, Qilu Pharmaceutical.Under the terms of the global supply agreement, Qilu will be part of the manufacturing network for global commercial supply of Vicineum drug substan...
Technology transfer to Qilu Pharmaceutical on track for completion in 2021 Sesen Bio to receive $2M milestone payment upon completion of technology transfer Sesen Bio (Nasdaq: SESN ), a late-stage clinical company developing targeted fusion protein therapeuti...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...